Ameriprise Financial Inc Royalty Pharma PLC Transaction History

Ameriprise Financial Inc

$375 Billion
Q4 2024

A detailed history of Ameriprise Financial Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Ameriprise Financial Inc holds 24,232 shares of RPRX stock, worth $816,618. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,232

Previous 48,018 49.54%

Holding current value

$816,618

Previous $1.36 Million 54.49%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 14, 2025	SELL	$24.28 - $28.39 $577,524 - $675,284	-23,786 Reduced 49.54%	24,232 $618,000
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $77,505 - $88,512	3,024 Added 6.72%	48,018 $1.36 Million
Q2 2024 Aug 14, 2024	SELL	$26.26 - $29.9 $3.48 Million - $3.96 Million	-132,364 Reduced 74.63%	44,994 $1.19 Million
Q1 2024 May 15, 2024	BUY	$27.46 - $31.33 $296,732 - $338,551	10,806 Added 6.49%	177,358 $5.39 Million
Q4 2023 Feb 14, 2024	SELL	$26.21 - $29.22 $59.5 Million - $66.4 Million	-2,271,500 Reduced 93.17%	166,552 $4.68 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $6.02 Million - $7.19 Million	229,165 Added 10.37%	2,438,052 $66.2 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $21.4 Million - $26.4 Million	723,451 Added 48.7%	2,208,887 $67.9 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $3.22 Million - $3.87 Million	98,288 Added 7.09%	1,485,436 $53.5 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $505,567 - $568,424	12,907 Added 0.94%	1,387,148 $54.8 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $3.37 Million - $3.77 Million	84,542 Added 6.56%	1,374,241 $55.2 Million
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $90,747 - $106,923	-2,418 Reduced 0.19%	1,289,699 $54.2 Million
Q1 2022 May 16, 2022	SELL	$37.46 - $42.44 $320,432 - $363,031	-8,554 Reduced 0.66%	1,292,117 $50.3 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $295,779 - $357,256	8,410 Added 0.65%	1,300,671 $51.8 Million
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $2.17 Million - $2.53 Million	-59,915 Reduced 4.43%	1,292,261 $46.7 Million
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $3.52 Million - $4.12 Million	88,292 Added 6.99%	1,352,176 $55.4 Million
Q1 2021 May 17, 2021	BUY	$42.34 - $52.82 $20 Million - $24.9 Million	471,201 Added 59.44%	1,263,884 $55.2 Million
Q4 2020 Feb 12, 2021	BUY	$36.12 - $50.05 $6.21 Million - $8.61 Million	171,965 Added 27.7%	792,683 $39.7 Million
Q3 2020 Nov 16, 2020	SELL	$38.56 - $48.36 $31 Million - $38.9 Million	-804,652 Reduced 56.45%	620,718 $26.1 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $63.4 Million - $74.3 Million	1,425,370 New	1,425,370 $69.2 Million

Others Institutions Holding RPRX

# of Institutions

434

Shares Held

294M

Call Options Held

508K

Put Options Held

118K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.7B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Royalty Pharma PLC Transaction History